Shares in Georg Fischer, the Swiss manufacturing company, dropped by 3.8% on Thursday following the release of their first-half financial results. The company reported a decrease in net profit and sales due to unfavorable exchange rates. Earlier in the day, shares had tumbled more than 5%. Financial Report Highlights Net profit in the January to June period dropped to 123 … [Read more...] about Georg Fischer’s Shares Decline on Lower First-Half Profits
Forex News
Vingegaard Wins Second Consecutive Tour de France
PARIS — Danish rider Jonas Vingegaard sealed his second consecutive victory at the Tour de France, as the iconic race concluded on the renowned Champs-Élysées. With a substantial lead over his main competitor, Tadej Pogačar, the 2020 and 2021 champion, Vingegaard knew that the victory was essentially secured before the largely ceremonial final stage of the 110th edition of the … [Read more...] about Vingegaard Wins Second Consecutive Tour de France
Georg Fischer Reports Net Profit and Sales Drop in First Half of 2023
Georg Fischer, the Swiss manufacturing company, has announced a slight decrease in net profit and sales for the first half of 2023. This drop can be attributed to the negative impact of unfavorable exchange rates, although it was partially offset by price adjustments. Financial Performance In precise figures, the net profit for the first half of the year amounted to 123 million … [Read more...] about Georg Fischer Reports Net Profit and Sales Drop in First Half of 2023
Julius Baer Gruppe Reports Increased Earnings in First Half of 2023
Julius Baer Gruppe Reports Increased Earnings in First Half of 2023 Julius Baer Gruppe has announced higher earnings for the first half of 2023, thanks to rising interest rates. The Swiss private banking group revealed that net profit for the period grew by 18% compared to the previous year, reaching 531 million Swiss francs ($614.2 million). Operating income stood at CHF2.03 … [Read more...] about Julius Baer Gruppe Reports Increased Earnings in First Half of 2023
Kodiak Sciences Ends Development of Lead Investigational Medicine
Shares of Kodiak Sciences plunged by over 50% in premarket trading on Monday as the biopharmaceutical company announced the termination of its lead investigational medicine, tarcocimab tedromer. This decision comes after the failure of two Phase 3 studies focusing on the treatment of diabetic macular edema. Disappointing Results in Phase 3 Studies Kodiak Sciences, headquartered … [Read more...] about Kodiak Sciences Ends Development of Lead Investigational Medicine
